Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

The PRNP Gene, Subtypes, and Disease Mechanism

At a Glance

Familial Alzheimer-like prion disease results from an inherited PRNP change that makes prion protein misfold and damage brain cells. Because symptoms and some test results can resemble Alzheimer’s, diagnosis combines genetic testing with specialist review and tests for prion activity or tissue changes.

To understand familial Alzheimer-like prion disease, it helps to look at the brain’s genetic instructions. Every person has a gene called PRNP, which provides the instructions for making the Prion Protein (PrP). Normally, these proteins are healthy and perform important tasks in the brain. However, in people with this condition, a pathogenic variant (mutation) in the PRNP gene causes the body to build abnormal proteins that can damage brain cells [1][2].

The Misfolding Mechanism

While typical Alzheimer’s disease is defined by the buildup of two proteins called amyloid-beta and tau, these rare genetic diseases are driven primarily by the PrP protein [3][4]. When the mutated PrP misfolds, it acts as a template, causing healthy proteins to also misfold. This accumulation eventually leads to neuronal death and brain tissue damage [1][5].

The reason this is often confused with Alzheimer’s is that the damage happens in similar areas of the brain, and in some rare variants, the presence of these prions has been reported to trigger the formation of tau tangles—the same tangles found in Alzheimer’s [6][7].

Specific Mutations that Can Mimic Alzheimer’s

Researchers have identified several specific variants in the PRNP gene that have been reported to resemble Alzheimer’s. It is important to note that these are based on limited and heterogeneous case reports, not absolute rules:

  • PRNP Y157X: This is a “truncating” mutation. Case reports suggest it can cause a slow decline in memory and thinking. Remarkably, patients with this mutation may show elevated p-tau181 in blood tests—a marker doctors often use to support an Alzheimer’s diagnosis [8][9]. It has also been reported to affect the body outside the brain, causing nerve pain (peripheral neuropathy) or chronic nausea [8][10].
  • PRNP T107I: This is a missense mutation that affects a specific cluster of the protein. Families with this variant have experienced a slow cognitive decline that resembles Alzheimer’s but may eventually be joined by motor symptoms like stiffness or difficulty walking [11].
  • Octapeptide-Repeat Insertions (OPRI): This mutation involves an “extra” section of genetic code that repeats itself. For example, a 5-OPRI mutation means there are five extra repeats. These cases are highly variable; some people may show personality changes (frontotemporal-like symptoms), while others have memory loss and muscle jerks (myoclonus) [12][13].

The Role of Codon-129: A Disease Modifier

Even among family members with the exact same mutation, the disease can look different. This is often due to Codon-129, a specific polymorphism on the PRNP gene that acts as a modifier [14]. Every person has two alleles at this location, either M (Methionine) or V (Valine).

  • MM (Homozygous): Often associated with an earlier age of onset in some mutations, such as 5-OPRI [12].
  • MV (Heterozygous): In many cases, having two different letters (M and V) can act as a modifier that sometimes influences a later onset or a different pattern of symptoms, though this is probabilistic, not a general protective rule [15][12].
  • V/V: This combination can also influence how long the disease lasts once symptoms begin [16].
    Codon-129 is a modifier, not the disease-causing mutation itself, and should not be used alone for personal prognostic counseling.

Prion Protein vs. Amyloid-Beta

In typical Alzheimer’s, the primary protein involved is amyloid-beta. In this disease, the primary protein is the mutated PrP. However, because the mutated PrP can cause PrP-Cerebral Amyloid Angiopathy (a buildup of prion protein—not amyloid-beta—in the blood vessels) and tau tangles, even advanced brain scans and spinal fluid tests can be misleading [8][17].

This is why genetic testing is a crucial component of specialist evaluation. It helps identify an inherited variant, but it does not necessarily prove it is the sole protein species causing current symptoms. Genetic testing must be combined with tests like CSF RT-QuIC or neuropathological examination for a full diagnosis [18][15].

Common questions in this guide

How can a PRNP mutation cause symptoms that look like Alzheimer’s disease?
A harmful change in the PRNP gene can make the prion protein misfold and build up, damaging brain cells. This can cause memory and thinking problems in brain regions also affected by Alzheimer’s disease, but the main protein involved is different.
Which PRNP variants are linked to Alzheimer-like symptoms?
Reports describe Alzheimer-like patterns with PRNP Y157X, PRNP T107I, and octapeptide-repeat insertions such as 5-OPRI. Reported symptoms vary: some people have slow memory decline, while others develop personality changes, movement problems, nerve pain, nausea, or muscle jerks. These findings come from limited and varied case reports, so a variant does not predict one exact course.
What does a codon-129 result mean in familial prion disease?
Codon-129 is a site in the PRNP gene where a person may have methionine (M) or valine (V) on each copy, producing MM, MV, or VV. This pattern may influence age at onset, symptom pattern, or disease duration, but it is a modifier rather than the disease-causing mutation. It should not be used alone to predict an individual’s prognosis.
Can an elevated p-tau181 result be mistaken for Alzheimer’s disease?
Yes. Some reports of people with PRNP Y157X describe elevated blood p-tau181, a marker often used in Alzheimer’s evaluations. This result alone does not prove typical Alzheimer’s disease, because prion-related changes and coexisting Alzheimer’s pathology may need to be considered separately.
What tests help confirm familial Alzheimer-like prion disease?
Genetic testing can identify a pathogenic PRNP variant, but it does not by itself prove which protein is driving current symptoms. Specialists may combine the genetic result with a spinal-fluid test called CSF RT-QuIC and, when appropriate, examination of brain tissue after death. The full interpretation depends on the symptoms and the complete clinical evaluation.
What symptoms might occur in addition to memory loss?
Depending on the PRNP variant, families may notice stiffness or difficulty walking, personality changes, muscle jerks, nerve pain, or persistent nausea in addition to memory and thinking problems. The course can vary substantially between families and even among people with the same mutation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific PRNP mutation does my loved one have (e.g., Y157X, T107I, or an OPRI), and how does it typically progress in reported cases?
  2. 2.What is the codon-129 genotype (MM, MV, or VV), and how might this act as a modifier for the timing of symptoms?
  3. 3.Since some biomarkers like p-tau181 can be elevated in this condition, how can we distinguish between prion-related changes and coexisting Alzheimer’s pathology?
  4. 4.Are there specific symptoms we should watch for that are unique to this mutation, such as nerve pain, digestive issues, or motor changes?
  5. 5.Does this mutation mean that a brain autopsy is the only way to confirm the exact protein involved, or are there other tests we should consider?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Requirements for mutant and wild-type prion protein misfolding in vitro.

    Noble GP, Walsh DJ, Miller MB, et al.

    Biochemistry 2015; (54(5)):1180-7 doi:10.1021/bi501495j.

    PMID: 25584902
  2. 2

    Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.

    Asante EA, Linehan JM, Tomlinson A, et al.

    PLoS biology 2020; (18(6)):e3000725 doi:10.1371/journal.pbio.3000725.

    PMID: 32516343
  3. 3

    Genetic causes and modifiers of prion diseases.

    Mead S, Hermann P, Mok TH, et al.

    The Lancet. Neurology 2026; (25(2)):181-194 doi:10.1016/S1474-4422(25)00451-X.

    PMID: 41579904
  4. 4

    Genetic Factors in Mammalian Prion Diseases.

    Mead S, Lloyd S, Collinge J

    Annual review of genetics 2019; (53()):117-147 doi:10.1146/annurev-genet-120213-092352.

    PMID: 31537104
  5. 5

    Convergent generation of atypical prions in knockin mouse models of genetic prion disease.

    Mehra S, Bourkas ME, Kaczmarczyk L, et al.

    The Journal of clinical investigation 2024; (134(15)).

    PMID: 39087478
  6. 6

    Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-Scheinker disease.

    Hallinan GI, Ozcan KA, Hoq MR, et al.

    Acta neuropathologica 2022; (144(3)):509-520 doi:10.1007/s00401-022-02461-0.

    PMID: 35819518
  7. 7

    Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

    Fong JC, Rojas JC, Bang J, et al.

    Journal of Alzheimer's disease : JAD 2017; (55(1)):249-258 doi:10.3233/JAD-160300.

    PMID: 27716661
  8. 8

    Inherited prion disease caused by a novel frameshift mutation of PRNP resulting in protein truncation at codon 157.

    Holm-Mercer L, Mok TH, Sequeira D, et al.

    Journal of Alzheimer's disease : JAD 2025; (106(3)):1087-1096 doi:10.1177/13872877251351182.

    PMID: 40611688
  9. 9

    Variable tau accumulation in murine models with abnormal prion protein deposits.

    Piccardo P, King D, Brown D, Barron RM

    Journal of the neurological sciences 2017; (383()):142-150 doi:10.1016/j.jns.2017.10.040.

    PMID: 29246602
  10. 10

    A new prion disease: relationship with central and peripheral amyloidoses.

    Mead S, Reilly MM

    Nature reviews. Neurology 2015; (11(2)):90-7 doi:10.1038/nrneurol.2014.263.

    PMID: 25623792
  11. 11

    The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer's disease.

    Holm-Mercer L, Coysh T, Mok TH, et al.

    Journal of neurogenetics 2025; (39(1)):16-22 doi:10.1080/01677063.2024.2440395.

    PMID: 39789805
  12. 12

    Genetic Creutzfeldt-Jakob disease associated with 5-octapeptide repeat insertion in the PRNP gene: case and pedigree report and literature review.

    Geng Q, Liu R, Xia J, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(6)).

    PMID: 42185544
  13. 13

    Case Report: Histopathology and Prion Protein Molecular Properties in Inherited Prion Disease With a De Novo Seven-Octapeptide Repeat Insertion.

    Cali I, Cracco L, Saracino D, et al.

    Frontiers in cellular neuroscience 2020; (14()):150 doi:10.3389/fncel.2020.00150.

    PMID: 32733203
  14. 14

    Genetic Creutzfeldt-Jakob disease linked to the E200K mutation: a large cohort study.

    Appleby BS, Manca M, Piazza MS, et al.

    Acta neuropathologica 2026; (151(1)):5 doi:10.1007/s00401-026-02975-x.

    PMID: 41528501
  15. 15

    Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.

    Schmitz M, Villar-Piqué A, Hermann P, et al.

    Brain : a journal of neurology 2022; (145(2)):700-712 doi:10.1093/brain/awab350.

    PMID: 35288744
  16. 16

    Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP).

    Van den Broecke A, Decruyenaere A, Schuermans N, et al.

    Journal of neurology 2024; (271(1)):263-273 doi:10.1007/s00415-023-11968-9.

    PMID: 37689591
  17. 17

    Structure of Tau filaments in Prion protein amyloidoses.

    Hallinan GI, Hoq MR, Ghosh M, et al.

    Acta neuropathologica 2021; (142(2)):227-241 doi:10.1007/s00401-021-02336-w.

    PMID: 34128081
  18. 18

    Inherited Prion Disease with a 5-octapeptide Repeat Insertion in the PRNP Gene Presenting with Familial Juvenile Dementia.

    Nishikawa M, Takeda A, Miyazawa N, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(18)):2769-2773 doi:10.2169/internalmedicine.5143-24.

    PMID: 40058853

This page is for informational purposes only and does not constitute medical advice. A neurologist or genetic counselor should interpret PRNP testing, codon-129 results, and symptoms in the context of your family’s care.

Get notified when new evidence is published on Familial Alzheimer-like prion disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.